Table VII.

Overall and cancer–specific survival – clinical parameters’ influence in reTURB or non-reTURB groups

Parameter		All Log-rank p	reTURB group Log-rank p	Non-reTURB group Log-rank p	Cox HR (95% CI)/p Multivariate
Gender (F/M)	OS	0.132	0.691	0.130	n.s.
	CSS	0.693	0.926	0.555	n.s.
Ta/T1	OS	0.809	0.553	0.742	n.s.
	CSS	0.365	n. a.	0.266	n.a.
HG/LG	OS	0.005	0.913	< 0.001	n.s.
	CSS	0.001	0.494	< 0.001	3.05 (1.23–7.52)/0.016
Muscle in primary TURB specimen, no/yes	OS	0.108	0.449	0.144	n.s.
	CSS	0.708	0.741	0.469	n.s.
Lamina propria focal/massive infiltration (T1)	OS	0.015	0.007	0.320	0.60 (0.38–0.94)/0.026
	CSS	< 0.001	0.005	0.024	0.33 (0.18–0.62)/0.001
Concomitant CIS, no/yes	OS	0.231	0.181	0.694	n.s.
	CSS	0.011	0.233	0.068	0.38 (0.19–0.75)/0.005
EORTC risk group (intermediate/high)	OS	0.065	0.871	0.047	n.s.
	CSS	0.222	0.925	0.101	n.a.
Focality (solitary/multiple)	OS	0.274	0.056	0.904	n.s.
	CSS	0.793	0.725	0.559	n.s.
Primary/recurrent	OS	0.468	0.603	0.290	n.s.
	CSS	0.694	0.674	0.817	n.s.
Size (< 3 cm/> 3 cm)	OS	0.163	0.183	0.463	n.s.
	CSS	0.127	0.218	0.371	n.s.
reTURB, no/yes	OS	0.382	–	–	n.s.
	CSS	0.097	–	–	n.s.

F – female, M – male, OS – overall survival, CSS – cancer-specific survival, TURB – transurethral resection of bladder tumour, CIS – carcinoma in situ, HR – hazard ratio, 95% CI – 95% confidence interval, the value of adjusted p < 0.05 was considered statistically significant (bolded); HR > 1 better outcome when reTURB performed, HR < 1 worse outcome when reTURB performed.